Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cotrimoxazole in Idiopathic Pulmonary Fibrosis
NCT01777737Phase 3Terminated
- Sponsor
- Fundación Pública Andaluza para la Gestión de la Investigación
- Start
- Nov 2013
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of trimethoprim + sulfamethoxazole in idiopathic pulmonary fibrosis (IPF), sponsored by Fundación Pública Andaluza para la Gestión de la Investigación. Started Nov 2013; status: terminated.
02
Drugs
trimethoprim + sulfamethoxazole
03
Conditions
idiopathic pulmonary fibrosis (IPF)
Beyond the preview
Go deeper on NCT01777737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01777737.